Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 11-20 of 47 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Current status of therapeutic drug monitoring in Australia and New Zealand: A need for improved assay evaluation, best practice guidelines, and professional developmentNorris, R.; Martin, J.; Thompson, E.; Ray, J.; Fullinfaw, R.; Joyce, D.; Barras, M.; Jones, G.; Morris, R.
2010Frequently discordant results from therapeutic drug monitoring for digoxin: clinical confusion for the prescriberRogers, N.; Jones, T.; Morris, R.
2002Cyclosporin monitoring in Australasia: Survey of laboratory practices in 2000Morris, R.; Lam, A.
2004Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady stateJones, T.; Morris, R.; Horowitz, J.
2002International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoringHolt, D.; Armstrong, V.; Griesmacher, A.; Morris, R.; Napoli, K.; Shaw, L.
2005CEDIAÒ sirolimus assay compared with HPLC-MS/MS and HPLC-UV in transplant recipient specimensWestley, I.; Morris, R.; Taylor, P.; Salm, P.; James, M.
2002Cyclosporin monitoring in Australasia: 2002 update of concensus guidelinesMorris, R.; Ilet, K.; Tett, S.; Ray, J.; Fullinfaw, R.; Cooke, R.; Cook, S.
2002Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral®) at day 7 post-renal transplantation and incidence of rejection in the first monthMorris, R.; Russ, G.; Cervelli, M.; Juneja, R.; McDonald, S.; Mathew, T.
2002Pharmacokinetic interaction between tacrolimus and diltiazem - dose-response relationship in kidney and liver transplant recipientsJones, T.; Morris, R.
2004Analytic aspects of cyclosporine monitoring, on behalf of the IFCC/IATDMCT joint working groupMorris, R.; Holt, D.; Armstrong, V.; Griesmacher, A.; Napoli, K.; Shaw, L.